tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

UNCY Stock Latest News

Unicycive presents on development progress of oxylanthanum carbonate
The FlyUnicycive presents on development progress of oxylanthanum carbonate
7d ago
UNCY
Unicycive Therapeutics completes UNI-494 Phase 1 study
PremiumThe Fly
Unicycive Therapeutics completes UNI-494 Phase 1 study
26d ago
UNCY
Unicycive Therapeutics submits NDA to FDA for oxylanthanum carbonate
PremiumThe Fly
Unicycive Therapeutics submits NDA to FDA for oxylanthanum carbonate
2M ago
UNCY
Unicycive price target lowered to $2.50 from $4.50 at H.C. Wainwright
PremiumThe Fly
Unicycive price target lowered to $2.50 from $4.50 at H.C. Wainwright
3M ago
UNCY
Unicycive Therapeutics reports Q2 EPS (15c), consensus (19c)
PremiumThe Fly
Unicycive Therapeutics reports Q2 EPS (15c), consensus (19c)
3M ago
UNCY
Is UNCY a Buy, Before Earnings?
PremiumPre-EarningsIs UNCY a Buy, Before Earnings?
3M ago
UNCY
Unicycive Therapeutics management to meet virtually with Piper Sandler
Premium
The Fly
Unicycive Therapeutics management to meet virtually with Piper Sandler
3M ago
UNCY
Unicycive Therapeutics granted patent on UNI-494 from USPTO
Premium
The Fly
Unicycive Therapeutics granted patent on UNI-494 from USPTO
4M ago
UNCY
Unicycive announces initial results from patient reported outcome survey on OLC
PremiumThe Fly
Unicycive announces initial results from patient reported outcome survey on OLC
4M ago
UNCY
Unicycive Therapeutics initiated with a Buy at Brookline
PremiumThe Fly
Unicycive Therapeutics initiated with a Buy at Brookline
4M ago
UNCY
Unicycive Therapeutics files to sell 50M shares of common stock for holders
PremiumThe Fly
Unicycive Therapeutics files to sell 50M shares of common stock for holders
4M ago
UNCY
Unicycive Therapeutics joins Russell Microcap Index
PremiumThe Fly
Unicycive Therapeutics joins Russell Microcap Index
4M ago
UNCY
Unicycive Therapeutics Reports Clinical Trial Breakthrough
PremiumCompany AnnouncementsUnicycive Therapeutics Reports Clinical Trial Breakthrough
4M ago
8K
UNCY
Unicycive Therapeutics achieves study objective in OLC clinical trial
Premium
The Fly
Unicycive Therapeutics achieves study objective in OLC clinical trial
4M ago
UNCY
Unicycive Therapeutics delivers presentations on OLC, UNI-494
Premium
The Fly
Unicycive Therapeutics delivers presentations on OLC, UNI-494
5M ago
UNCY
Unicycive Therapeutics presents new data on OLC at NKF meeting
PremiumThe Fly
Unicycive Therapeutics presents new data on OLC at NKF meeting
6M ago
UNCY
Unicycive Therapeutics reports Q1 EPS (61c), consensus (15c)
PremiumThe Fly
Unicycive Therapeutics reports Q1 EPS (61c), consensus (15c)
6M ago
UNCY
These 2 ‘Strong Buy’ Penny Stocks Could Rally to $9, Says Piper Sandler
PremiumStock Analysis & Ideas
These 2 ‘Strong Buy’ Penny Stocks Could Rally to $9, Says Piper Sandler
6M ago
TSHA
UNCY
Unicycive Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe Fly
Unicycive Therapeutics initiated with an Overweight at Piper Sandler
7M ago
UNCY
Unicycive Therapeutics reports FY23 EPS ($1.28), consensus ($1.24)
PremiumThe FlyUnicycive Therapeutics reports FY23 EPS ($1.28), consensus ($1.24)
7M ago
UNCY
Unicycive Therapeutics to sell 50,000 shares at $1,000 in private placement
Premium
The Fly
Unicycive Therapeutics to sell 50,000 shares at $1,000 in private placement
8M ago
UNCY
Unicycive Therapeutics presents on UNI-494 at AKI, CRRT conference
Premium
The Fly
Unicycive Therapeutics presents on UNI-494 at AKI, CRRT conference
8M ago
UNCY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >